Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing dehydrocholic acid and dimeticone and pancreatin in oral dose form (medicinal product form) |
Is a |
Dimeticone-containing product in oral dose form |
false |
Inferred relationship |
Some |
|
|
Product containing dehydrocholic acid and dimeticone and pancreatin in oral dose form (medicinal product form) |
Is a |
Product containing dehydrocholic acid and dimeticone and pancreatin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Product containing dehydrocholic acid and dimeticone and pancreatin in oral dose form (medicinal product form) |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Some |
|
|
Product containing dehydrocholic acid and dimeticone and pancreatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
A substance containing enzymes, mainly amylase, lipase, and protease, obtained from the pancreas of the hog or of the ox. It is a cream-coloured, amorphous powder, having a faint, characteristic, but not offensive odour. Its greatest activities are in neutral or faintly alkaline media; more than traces of mineral acids or large amounts of alkali hydroxides make it inert. An excess of alkali carbonate also inhibits its action. Pancreatin contains, in each mg, not less than 25 USP units of amylase activity, not less than 2 USP units of lipase activity, and not less than 25 USP units of protease activity. Pancreatin of a higher digestive power may be labelled as a whole-number multiple of the 3 minimum activities, or may be diluted with lactose, or with sucrose containing not more than 3.25% of starch, or with pancreatin of lower digestive power. |
false |
Inferred relationship |
Some |
1 |
|
Product containing dehydrocholic acid and dimeticone and pancreatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dehydrocholic acid (substance) |
false |
Inferred relationship |
Some |
2 |
|
Product containing dehydrocholic acid and dimeticone and pancreatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dimeticone (substance) |
false |
Inferred relationship |
Some |
3 |
|
Product containing dehydrocholic acid and dimeticone and pancreatin in oral dose form (medicinal product form) |
Plays role |
Digestant therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|